Navigation Links
Leiner Health Products Submits Proposed Agreement with Department of Justice to U.S. Bankruptcy Court for Approval
Date:5/9/2008

Resolves Allegations of Compliance Matters at Defunct Facility

CARSON, Calif., May 9 /PRNewswire/ -- Leiner Health Products Inc. ("Leiner" or "the Company") announced today that it has submitted a proposed agreement with the United States Department of Justice to the U.S. Bankruptcy Court in Delaware for approval. The proposed agreement would resolve the previously disclosed investigation concerning the production, control and distribution of certain over-the-counter (OTC) drug products at the Company's now defunct Fort Mill, South Carolina facility. The agreement is subject to approval and acceptance by the United States District Court in Columbia, South Carolina.

This agreement would resolve the government's investigation of allegations against Leiner, which were related to a previously disclosed Form 483 report the Company received from the Food and Drug Administration (FDA) on March 16, 2007. Both the investigation and the Form 483 pertained to activities that took place at the now closed Fort Mill facility prior to the arrival of the current Quality Control management team.

"Leiner took immediate action to correct this situation," said Robert K. Reynolds, CEO and President of Leiner. "In addition to the closure of the affected facility, we also restructured our Quality Control systems, including top to bottom personnel changes and implementation of strengthened compliance programs to ensure that all products conform to Leiner's rigorous standards."

Under the terms of the agreement, Leiner Health Products, LLC, a subsidiary of Leiner Health Products Inc., would enter a plea of guilty to one count of mail fraud and would forfeit $10 million in cash in lieu of a fine. The agreement in no way implicates or affects Leiner's ability to manufacture and distribute vitamin and mineral products.

Mr. Reynolds continued, "We are pleased to put these issues behind us, and we are committed to providing consumers with the best valu
'/>"/>

SOURCE Leiner Health Products Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Breathe Technologies, Inc. Closes on $15 Million in Venture Funding Led by Kleiner Perkins Caufield & Byers
2. Penn study finds pro-death proteins required to regulate healthy immune function
3. UCLA researchers identify markers that may predict diabetes in still-healthy people
4. Air pollution linked to cardiovascular risk indices in healthy young adults
5. More proof needed of safety and quality of electronic personal health records
6. Health care incentive model offers collaborative approach
7. Loneliness is bad for your health
8. Mailman School of Public Health study examines link between racial discrimination and substance use
9. Green Tea May Brew Up Healthier Skin
10. For Health Info, Women Often Turn to the Web
11. Record Number of Americans Lack Health Insurance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/11/2008)...ay 11 /PRNewswire/ -- The winners of today,s Susan...ollows:, 1st Place Overall Winners Male: ...le: Kelly Knickelbein, Pittsburgh, Pa., 19:19, 2... 16:02 Female: Anna Beck, Washington, Pa., 1...ie Ban, Pittsburgh, Pa., 16:13 Female: Jessi...
(Date:5/11/2008)...norCare Facilities, Caregivers Call for Better Car...swire-USNewswire/ -- Families visiting their,loved...in sixteen states,across the nation this Mother,s ...from quality care advocates. The effort asks famil...Director David Rubenstein to demand better,care. I...
(Date:5/10/2008)...ay 10 /PRNewswire/ -- Children,s Hospital of Pitts...ts new state-of-the-art hospital,campus., (Photo:...A001 ), When the new Children,s Hospital opens i... care nationwide. The new hospital building will,s...ment project that is,situated on a 10-acre campus....
(Date:5/9/2008)...cation Indicated for Maintenance Treatment for ADH...Eli Lilly and Company,(NYSE: LLY ) announced toda...ion (FDA) has approved Strattera(R) (atomoxetine H.../Hyperactivity Disorder (ADHD) in,children and ado...uptake,inhibitor, is the first FDA-approved non-st...
Breaking Medicine News(10 mins):Health News:16th Annual Komen Pittsburgh Race for the Cure(R) Winners Announced 2Health News:Advocates Make Mother's Day Push for Quality Care 2Health News:ONE YEAR Until the New Children's Hospital of Pittsburgh of UPMC Opens in Lawrenceville 2Health News:ONE YEAR Until the New Children's Hospital of Pittsburgh of UPMC Opens in Lawrenceville 3Health News:ONE YEAR Until the New Children's Hospital of Pittsburgh of UPMC Opens in Lawrenceville 4Health News:FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents 2Health News:FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents 3Health News:FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents 4Health News:FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents 5Health News:FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents 6
...ions for nurses are safer for elderly intensive ca...rt , led by researchers that measured rates of ho...infections are the number six cause of death in th...largest workforce in the nation's hospitals, are i...
...oyable process. Why spoil it by seeking the help o...ers . Delivering their own babies at home, often ...g" by doctors and midwives and confidently catch t... leave the womb. "Birthing uses the same hormone...
...alo have revealed that women who regularly enjoy a...r risk of having a non-fatal heart attack than wo...dy who reported being intoxicated at least once a ...ikely to suffer a heart attack than abstainers, re...
...rtmouth University have explained the biological m...nsible for why people get sleepy at night and wak...at transfers energy from light to chemical reactio...g, mental illness, and even some forms of cancer i...
Other Medicine News:Health News:Better Working Conditions for Nurses Might Decrease Patient Infections 2Health News:Better Working Conditions for Nurses Might Decrease Patient Infections 3Health News:Delivering Baby, the Natural Way. 2Health News:A Tipple a Day may Be heart Friendly for Women 2Health News:Circadian Clocks Triggered Chemical Reactions may Be Behind Jet Lag 2
(Date:5/8/2008)...Efficacy and safety data support potential of asen...hrenia and bipolar I disorder, WASHINGTON, May 8 ...ion,(NYSE: SGP ) today announced that an overview...gram was presented at the 161st Annual Meeting of ..., D.C., May 3-8. Data from,the studies, involving ...
(Date:5/8/2008)... Results presented at the 27th Annual Meeting of t... (APS), SMYRNA, Ga., May 8 /- ...ained pain relief from diabetic neuropathic pain (...ing to data presented at the,27th annual meeting o... "This is the first placebo-controlled trial of a ...
(Date:5/8/2008)... HOUSTON, May 8 /- Go He... of further clinical trials with Cholesterade (R),... clinical group of 200,patients in 6 centers aroun...icine Institute at The Methodist Hospital in the T...rial. Dr. Bryan was formerly the Team,Physician fo...
(Date:5/7/2008)... A new study shows how sounds are amplified in ...aring loss can result from genetic mutation or,ove...re-USNewswire/ -- St. Jude Children,s,Research Hos...y powered,amplification mechanism in the cochlea o...ns and other mammals. The findings will enable bet...
Breaking Medicine Technology:Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 2Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 3Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 4Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 5Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 6Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 7New Lacosamide Data Provides Evidence for Long-Term Efficacy in Diabetic Neuropathic Pain 2New Lacosamide Data Provides Evidence for Long-Term Efficacy in Diabetic Neuropathic Pain 3New Lacosamide Data Provides Evidence for Long-Term Efficacy in Diabetic Neuropathic Pain 4Go Healthy Initiates Additional Clinical Tests on Cholesterade 2St. Jude Finds 'Dancing' Hair Cells Are Key to Humans' Acute Hearing 2St. Jude Finds 'Dancing' Hair Cells Are Key to Humans' Acute Hearing 3Ardea Biosciences Establishes Scientific Advisory Board for Inflammation Program 3514 1Ardea Biosciences Establishes Scientific Advisory Board for Inflammation Program 3514 2Ardea Biosciences Establishes Scientific Advisory Board for Inflammation Program 3514 3Boston Scientific Announces Addition to Clinical Sciences Organization 3511 1Boston Scientific Announces Addition to Clinical Sciences Organization 3511 2Boston Scientific Announces Addition to Clinical Sciences Organization 3511 3Boston Scientific Announces Addition to Clinical Sciences Organization 3511 4Teen Aggression May Really Be a State of Mind 12701 1Teen Aggression May Really Be a State of Mind 12701 2Teen Aggression May Really Be a State of Mind 12701 3Caliper Life Sciences Reports Fourth Quarter and Full Year 2007 Results 12698 1Caliper Life Sciences Reports Fourth Quarter and Full Year 2007 Results 12698 2Caliper Life Sciences Reports Fourth Quarter and Full Year 2007 Results 12698 3Caliper Life Sciences Reports Fourth Quarter and Full Year 2007 Results 12698 4Caliper Life Sciences Reports Fourth Quarter and Full Year 2007 Results 12698 5Caliper Life Sciences Reports Fourth Quarter and Full Year 2007 Results 12698 6Caliper Life Sciences Reports Fourth Quarter and Full Year 2007 Results 12698 7Caliper Life Sciences Reports Fourth Quarter and Full Year 2007 Results 12698 8Caliper Life Sciences Reports Fourth Quarter and Full Year 2007 Results 12698 9Caliper Life Sciences Reports Fourth Quarter and Full Year 2007 Results 12698 10Caliper Life Sciences Reports Fourth Quarter and Full Year 2007 Results 12698 11Caliper Life Sciences Reports Fourth Quarter and Full Year 2007 Results 12698 12Caliper Life Sciences Reports Fourth Quarter and Full Year 2007 Results 12698 13Caliper Life Sciences Reports Fourth Quarter and Full Year 2007 Results 12698 14
...E, Mass.--(BUSINESS WIRE)--Jun 5, 2007 - Elixir,Ph...al data,confirming ghrelin antagonism as a potenti...dy weight and managing blood glucose. The,data wer...,Endocrine Society,s 89th Annual Meeting, being he...velopment of drugs to treat and,prevent metabolic ...
...ults show risk of heart attack,comparable to two w... June 6, 2007 - A study,of more than 33,000 type...ublished today. This study shows that the incidenc...a surgery known as,coronary revascularization for ...betes treatments. The study results were,released ...
Other Medicine Technology:Elixir Pharmaceuticals Presents Additional Preclinical Data,Demonstrating the Potential of Ghrelin Antagonism to Regulate,Metabolism, Body Weight and Glycemic Control 2Elixir Pharmaceuticals Presents Additional Preclinical Data,Demonstrating the Potential of Ghrelin Antagonism to Regulate,Metabolism, Body Weight and Glycemic Control 3Elixir Pharmaceuticals Presents Additional Preclinical Data,Demonstrating the Potential of Ghrelin Antagonism to Regulate,Metabolism, Body Weight and Glycemic Control 4Newly Published Data from Large Study Support Cardiovascular Safety,of Avandia (Rosiglitazone Maleate) 2Newly Published Data from Large Study Support Cardiovascular Safety,of Avandia (Rosiglitazone Maleate) 3Newly Published Data from Large Study Support Cardiovascular Safety,of Avandia (Rosiglitazone Maleate) 4
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
Medicine Products: